{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:58:26Z","timestamp":1772164706276,"version":"3.50.1"},"reference-count":30,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mutations in BRCA1 and BRCA2 increase a woman's lifetime risk of developing breast cancer by 43% to 84%. It was originally postulated that BRCA1\/2-associated breast cancers develop more rapidly than sporadic cancers and may lack preinvasive lesions. More recent studies have found preinvasive lesions in prophylactic mastectomy specimens from mutation carriers; however, there is little information on the presence of preinvasive lesions in tissue adjacent to breast cancers. Our aim is to investigate the role of preinvasive lesions in BRCA-associated breast carcinogenesis.<\/jats:p>\n                  <jats:p>We retrospectively compared BRCA1\/2-associated breast cancers and sporadic breast cancers for the prevalence of preinvasive lesions [ductal carcinoma in situ (DCIS), lobular carcinoma in situ, and atypical lobular hyperplasia] in tissue adjacent to invasive breast cancers.<\/jats:p>\n                  <jats:p>Pathology was reviewed for 73 BRCA1\/2-associated tumors from patients with breast cancer. We selected 146 patients with mutation-negative breast cancer as age-matched controls. Among the BRCA1\/2-associated breast cancers, 59% had at least one associated preinvasive lesion compared with 75% of controls. Preinvasive lesions were more prevalent in BRCA2 mutation carriers than in BRCA1 mutation carriers (70% versus 52%, respectively). The most common preinvasive lesion in both groups was DCIS; 56% of BRCA1\/2-associated breast cancers and 71% of the sporadic breast cancers had adjacent intraductal disease, respectively.<\/jats:p>\n                  <jats:p>Preinvasive lesions, most notably DCIS, are common in BRCA1\/2-associated breast cancers. These findings suggest that BRCA1\/2-associated breast cancers progress through the same intermediate steps as sporadic breast cancers, and that DCIS should be considered as a part of the BRCA1\/2 tumor spectrum.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-08-0050","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T23:33:55Z","timestamp":1233099235000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["High Prevalence of Preinvasive Lesions Adjacent to BRCA1\/2-Associated Breast Cancers"],"prefix":"10.1158","volume":"2","author":[{"given":"Banu","family":"Arun","sequence":"first","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen J.","family":"Vogel","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Lopez","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deann","family":"Atchley","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine R.","family":"Broglio","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher I.","family":"Amos","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Kuerer","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance T.","family":"Albarracin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Biostatistics, 3Epidemiology, 4Surgical Oncology, and 5Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and 6Center for Medical Genetics, Evanston Northwestern Healthcare, Evanston, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2009,2,5]]},"reference":[{"key":"2022060815473780700_ bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.","volume":"91","author":"Peto","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2022060815473780700_ bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P","article-title":"Frequency of BRCA1\/BRCA2 mutations in a population-based sample of young breast carcinoma cases.","volume":"88","author":"Malone","year":"2000","journal-title":"Cancer"},{"key":"2022060815473780700_ bib3","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer.","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"2022060815473780700_ bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2022060815473780700_ bib5","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"2022060815473780700_ bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families.","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2022060815473780700_ bib7","first-page":"254","article-title":"An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families.","volume":"56","author":"Narod","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2022060815473780700_ bib8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/92.18.1529","article-title":"Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.","volume":"92","author":"Syrjakoski","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2022060815473780700_ bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"JAMA"},{"key":"2022060815473780700_ bib10","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"2022060815473780700_ bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"2022060815473780700_ bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of BRCA1 and BRCA2 mutations in a large United States sample.","volume":"24","author":"Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"2022060815473780700_ bib13","first-page":"3606","article-title":"Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.","volume":"9","author":"Palacios","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2022060815473780700_ bib14","first-page":"782","article-title":"The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.","volume":"6","author":"Lakhani","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2022060815473780700_ bib15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0046-8177(98)90427-0","article-title":"Pathobiologic characteristics of hereditary breast cancer.","volume":"29","author":"Lynch","year":"1998","journal-title":"Hum Pathol"},{"key":"2022060815473780700_ bib16","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/bcr953","article-title":"Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.","volume":"7","author":"Eerola","year":"2005","journal-title":"Breast Cancer Res"},{"key":"2022060815473780700_ bib17","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases.","volume":"349","author":"Breast Cancer Linkage Consortium","year":"1997","journal-title":"Lancet"},{"key":"2022060815473780700_ bib18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.","volume":"20","author":"Scheuer","year":"2002","journal-title":"J Clin Oncol"},{"key":"2022060815473780700_ bib19","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/cncr.20221","article-title":"The development of interval breast malignancies in patients with BRCA mutations.","volume":"100","author":"Komenaka","year":"2004","journal-title":"Cancer"},{"key":"2022060815473780700_ bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N Engl J Med"},{"key":"2022060815473780700_ bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0140-6736(05)65027-1","article-title":"In situ breast cancer and BRCA1.","volume":"348","author":"Sun","year":"1996","journal-title":"Lancet"},{"key":"2022060815473780700_ bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.11048","article-title":"Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.","volume":"97","author":"Adem","year":"2003","journal-title":"Cancer"},{"key":"2022060815473780700_ bib23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2022060815473780700_ bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2022060815473780700_ bib25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancer.","volume":"91","author":"Antoniou","year":"2004","journal-title":"Br J Cancer"},{"key":"2022060815473780700_ bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.293.8.964","article-title":"Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.","volume":"293","author":"Claus","year":"2005","journal-title":"JAMA"},{"key":"2022060815473780700_ bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.2005.04.0345","article-title":"Ductal carcinoma in situ in BRCA mutation carriers.","volume":"25","author":"Hwang","year":"2007","journal-title":"J Clin Oncol"},{"key":"2022060815473780700_ bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.2003.02.137","article-title":"High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.","volume":"21","author":"Hoogerbrugge","year":"2003","journal-title":"J Clin Oncol"},{"key":"2022060815473780700_ bib29","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.ejca.2006.05.027","article-title":"Numerous high-risk epithelial lesions in familial breast cancer.","volume":"42","author":"Hoogerbrugge","year":"2006","journal-title":"Eur J Cancer"},{"key":"2022060815473780700_ bib30","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/cncr.11225","article-title":"Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.","volume":"97","author":"Kauff","year":"2003","journal-title":"Cancer"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/2\/2\/122\/2335805\/122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/2\/2\/122\/2335805\/122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:27:43Z","timestamp":1654691263000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/2\/2\/122\/47760\/High-Prevalence-of-Preinvasive-Lesions-Adjacent-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,1]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,5]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-08-0050","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22523739.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6543900","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6543900.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22523739","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,1]]}}}